Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scynexis Inc
(NQ:
SCYX
)
1.660
-0.020 (-1.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scynexis Inc
< Previous
1
2
3
4
5
6
Next >
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024
August 09, 2024
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 23, 2024
Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!
Via
InvestorPlace
3 Stocks Under $10 With the Potential for Massive Gains
July 22, 2024
Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries.
Via
InvestorPlace
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.
Via
InvestorPlace
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Via
InvestorPlace
Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing?
May 20, 2024
Exploring SCYNEXIS INC (NASDAQ:SCYX)'s growth characteristics.
Via
Chartmill
Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025
May 31, 2024
Read here about the top under-$10 growth stocks primed for financial success through strategic partnerships and innovative product offerings.
Via
InvestorPlace
3 Stocks Under $10 With Mammoth Growth Prospects
May 23, 2024
Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors.
Via
InvestorPlace
SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024
May 08, 2024
SCYX stock results show that SCYNEXIS beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023
March 28, 2024
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
January 29, 2024
Via
Benzinga
SCYX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors with Losses to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
January 08, 2024
WHY: NEW YORK, NY - (NewMediaWire) - January 8, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SCYNEXIS, Inc. (NASDAQ: SCYX) between March 31, 2023 and...
Via
NewMediaWire
Topics
Lawsuit
Product Recall
Exposures
Financial
Legal
Product Safety
A Look Into Healthcare Sector Value Stocks
January 08, 2024
Via
Benzinga
SCYX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
January 06, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
SCYNEXIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
January 05, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
SCYNEXIS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
January 05, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
SCYX DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
January 04, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Product Recall
Exposures
Financial
Legal
Product Safety
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
January 04, 2024
Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 03, 2024
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
January 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 02, 2024
Via
Benzinga
SCYX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
January 01, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
SCYX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
December 29, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
December 28, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
SCYNEXIS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
December 27, 2023
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
December 25, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Product Recall
Exposures
Financial
Legal
Product Safety
SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
December 24, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
December 22, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Product Recall
Exposures
Financial
Legal
Product Safety
SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
December 20, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
SCYNEXIS ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
December 19, 2023
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.